Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants

Hepatology

Volumn 26, Issue 2, 1997, Pages 251-255

  Von Weizsäcker, Fritz ^a   Wieland, Stefan ^a   Köck, Josef ^a   Offensperger, Wolf Bernhard ^a   Offensperger, Silke ^a   Moradpour, Darius ^a   Blum, Hubert E ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; RIBOZYME;

GENE MUTATION; GENE THERAPY; GENETIC DISORDER; HEPATITIS B; HEPATITIS C; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RNA REPLICATION; RNA RNA HYBRIDIZATION; TRANSCRIPTION REGULATION; VIRUS HEPATITIS; VIRUS INHIBITION; VIRUS REPLICATION;

GENE THERAPY; HEPATITIS, VIRAL, HUMAN; HUMANS; MUTATION; OLIGONUCLEOTIDES, ANTISENSE; RNA, CATALYTIC; VIRAL INTERFERENCE;

EID: 0030852745     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260237     Document Type: Review

References (23)

1. Wands JR, Blum HE. Primary hepatocellular carcinoma [Editorial]. N Engl J Med 1991;325:729-731.
2. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
3. Blau HM, Springer ML. Muscle mediated gene therapy. N Engl J Med 1995;333:1554-1556.
4. McDonnell WM, Askari FK. DNA vaccines. N Engl J Med 1996;334:42-45.
5. Pardoll DM, Beckerleg AM. Exposing the immunology of naked DNA vaccines. Immunity 1995;3:165-169.
6. Kumar V, Sercarz E. Genetic vaccination: The advantages of going naked. Nat Med 1996;2:857-859.
7. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996;2:1122-1128.
8. Conry RM, Widera G, Lobuglio AF, Fuller JT, Moore SE, Barlow DL, Turner J, et al. Selected strategies to augment polynucleotide immunization. Gene Ther 1996;3:67-74.
9. Schirmbeck R, Bohm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995;69:5929-5934.
10. Davis HL, Michel M-L, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Gen 1993;2:1847-1851.
11. Kuhöber A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2 b mice. J Immunol 1996;156:3687-3695.
12. Davis HL, Schirmbeck R, Reimann J, Whalen RG. DNA-mediated immu-nization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 1995;6:1447-1456.
13. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M-L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci U S A 1996;93:12496-12501.
14. Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 1995;69:5859-5863.
15. Major ME, Vitvitski L, Mink MA, Schleef M, Whalen RG, Trepo C, Inchauspé G. DNA based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 1995;69:5798-5805.
16. Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR Jr, Wands JR. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. HEPATOLOGY 1996;24:14-20.
17. Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993;62:191-217.
18. Anderson WF. Human gene therapy. Science 1992;256:808-813.
19. Friedmann T. Progress toward human gene therapy. Science 1989;244:1275-1281.
20. Gutierrez AA, Lemoine NR, Sikora K. Gene therapy for cancer. Lancet 1992;339:715-721.
21. Miller AD. Human gene therapy comes of age. Nature 1992;357:455-460.
22. Ledley FD. Hepatic gene therapy: present and future. HEPATOLOGY 1993;18:1263-1273.
23. Zern MA, Kresina TF. Hepatic drug delivery and gene therapy. HEPATOLOGY 1997;25:484-491.